US 9156818
Hepatitis C virus inhibitors
granted A61KA61K38/21A61P
Quick answer
US patent 9156818 (Hepatitis C virus inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Oct 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K38/21, A61P, A61P31/14